Roche Shares Alzheimer’s Drug and Diagnostic Advances at AAIC 2025
At the Alzheimer’s Association International Conference, Roche shared new data on its investigational antibody trontinemab and its Elecsys pTau217 blood test.
At the Alzheimer’s Association International Conference, Roche shared new data on its investigational antibody trontinemab and its Elecsys pTau217 blood test.
Roche's PATHWAY anti-HER2/neu (4B5) test has received FDA approval to ID patients with HR-positive, HER2-ultralow metastatic breast cancer.
Roche announced the Elecsys Amyloid Plasma Panel shows promising results in accurately ruling out amyloid pathology in Alzheimer's disease.
The CLP May/June 2024 Tech Guide that appears in Clinical Lab Products (CLP) features a wide-range of products from top laboratory providers.
Read MoreThe May/June 2024 Tech Guide that appears in Clinical Lab Products (CLP) features a wide-range of products from top laboratory providers.
Read MoreRoche launched new analytical units, cobas c 703 and cobas ISE neo, for the cobas pro integrated solutions.
Read MoreRoche’s VENTANA DP 200 whole slide imaging system has received FDA clearance for diagnosing patients through digital pathology.
Read MoreRoche’s cobas liat COVID, Influenza A/B & RSV test, is a rapid RT-PCR assay that detects multiple respiratory viruses from a single sample.
Read MoreALZpath and Roche will develop a blood test for Alzheimer’s diagnosis using the pTau217 antibody on the Roche Elecsys platform.
Read MoreRoche and Hitachi High-Tech have extended their partnership for at least 10 more years and will continue to focus on advancing lab tech.
Read MoreRoche announced that its Tina-quant lipoprotein Lp(a) RxDx assay received Breakthrough Device Designation from the FDA.
Read MoreThe CLP March/April 2024 Tech Guide in Clinical Lab Products (CLP) showcases a diverse array of products from seven laboratory providers.
Read Moreche received FDA approval for its HPV self-collection solution, allowing individuals to collect their own samples.
Read MoreRoche’s Elecsys pTau217 assay could help rapidly broaden access to a more timely and accurate diagnosis of Alzheimer’s disease. Â
Read MoreRoche announced U.S. FDA approval of the cobas Malaria test for use on the cobas 6800/8800 Systems to aid healthcare professionals.
Read MoreSherlock Bio is making its proprietary AI platform freely available to anyone interested in developing diagnostics assays.
Read MoreRoche’s new suite of cloud-based solutions provides actionable insights to optimize operational outcomes in labs and point-of-care settings.
Read MorePathAI will exclusively work with Roche Tissue Diagnostics to develop AI-enabled digital pathology algorithms for companion diagnostics.
Read More